Genome & Company (KOSDAQ:314130)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,965.00
-185.00 (-5.87%)
At close: Nov 16, 2026

Genome & Company Market Cap

Genome & Company has a market cap or net worth of 155.07 billion as of November 16, 2026. It is the 23,841st most valuable company in the world and the 929th biggest in South Korea. Its market cap has increased by 64.91% in one year.

Market Cap
155.07B
Enterprise Value
129.79B
Revenue
24.46B
Global Rank
Country Rank
#929 South Korea
PE Ratio
n/a

Chart

Chart

Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 155.07B, an increase of 115.74%. That is a compound annual growth rate of 10.23%.

History

DateMarket Cap% Change
Nov 16, 2026155.07B-34.95%
Dec 30, 2025238.38B179.77%
Dec 30, 202485.21B-51.64%
Dec 28, 2023176.21B-28.34%
Dec 29, 2022245.90B-47.55%
Dec 30, 2021468.83B-55.28%
Dec 30, 2020 Pro Pro
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 26, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

CompanyMarket Cap
IMBiologics200.00B
IntoCell196.49B
HansBiomed179.12B
curacle co.,ltd.176.37B
Kangstem Biotech165.82B
NIBEC146.31B
Y-Biologics134.77B
ISU Abxis131.09B
Market Cap Rankings